{"id":3763,"date":"2026-11-17T18:35:49","date_gmt":"2026-11-17T18:35:49","guid":{"rendered":"https:\/\/tansan.com.tr\/?page_id=3763"},"modified":"2026-11-17T20:31:45","modified_gmt":"2026-11-17T20:31:45","slug":"kanser-tedavisinde-yeni-gelismeler","status":"publish","type":"page","link":"https:\/\/tansan.com.tr\/en\/kanser-tedavisinde-yeni-gelismeler\/","title":{"rendered":"New Developments in Cancer Treatment"},"content":{"rendered":"<p>Kanser tan\u0131s\u0131 alan bir ki\u015finin ilk sorular\u0131ndan biri, \u201cBenim i\u00e7in en uygun tedavi hangisi?\u201d olur. Yan\u0131t\u0131 bulmak, farkl\u0131 uzmanlar\u0131n birlikte \u00e7al\u0131\u015ft\u0131\u011f\u0131 multidisipliner yakla\u015f\u0131mla ba\u015flar. T\u0131bbi onkoloji, cerrahi, radyasyon onkolojisi, patoloji ve radyoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131; tan\u0131n\u0131n netle\u015ftirilmesine, hastal\u0131\u011f\u0131n yayg\u0131nl\u0131\u011f\u0131n\u0131n belirlenmesine ve tedavilerin do\u011fru s\u0131rayla planlanmas\u0131na yard\u0131mc\u0131 olur. Hastan\u0131n genel sa\u011fl\u0131\u011f\u0131, g\u00fcnl\u00fck ya\u015fam\u0131 ve tercihleri de bu plan\u0131n par\u00e7as\u0131d\u0131r. [1]\n<p>Patolojik tan\u0131, kanserin t\u00fcr\u00fcn\u00fc belirlemede temel yerini koruyor. Buna eklenen ayr\u0131nt\u0131l\u0131 molek\u00fcler incelemeler, t\u00fcm\u00f6r\u00fcn b\u00fcy\u00fcmesini y\u00f6nlendiren gen de\u011fi\u015fikliklerini ve tedavi se\u00e7iminde yol g\u00f6sterebilen proteinleri ara\u015ft\u0131r\u0131yor. Uygun hastalarda geni\u015f gen panelleri ve di\u011fer biyobelirte\u00e7 testleri sayesinde, ayn\u0131 organda geli\u015fse bile birbirinden farkl\u0131 davranabilen t\u00fcm\u00f6rleri daha iyi tan\u0131yoruz. B\u00f6ylece tedaviyi hem ki\u015fiye hem t\u00fcm\u00f6r\u00fcn \u00f6zelliklerine g\u00f6re planlayabiliyoruz; ancak her test sonucunun kullan\u0131labilir bir ilaca i\u015faret etmesi beklenmez. [2]\n<p>Kemoterapideki \u00f6nemli geli\u015fmelerden biri, antikor ila\u00e7 konjugatlar\u0131d\u0131r (ADC). Bu ila\u00e7larda antikor, kanser h\u00fccresindeki belirli bir hedefi tan\u0131r ve kendisine ba\u011fl\u0131 kemoterapiyi h\u00fccreye ta\u015f\u0131r. Kullan\u0131m alanlar\u0131 geni\u015fliyor: 2026\u2019da datopotamab derukstekan, PD-1\/PD-L1 imm\u00fcnoterapisine uygun olmayan, ameliyat edilemeyen veya metastatik \u00fc\u00e7l\u00fc negatif meme kanserli yeti\u015fkinler i\u00e7in ABD\u2019de onay ald\u0131. Bu hedefli ta\u015f\u0131ma, yan etkilerin ortadan kalkt\u0131\u011f\u0131 anlam\u0131na gelmez. [3,4]\n<p>Biyolojik ajanlar ve di\u011fer hedefe y\u00f6nelik ila\u00e7lar da tedavide \u00f6nemli bir yer tutuyor. Monoklonal antikorlar ve h\u00fccre i\u00e7indeki b\u00fcy\u00fcme sinyallerini engelleyen ila\u00e7lar, uygun hedef bulundu\u011funda hastal\u0131\u011f\u0131 kontrol etmeye yard\u0131mc\u0131 olabiliyor. Hangi ilac\u0131n, hangi s\u0131rayla veya hangi tedaviyle birlikte kullan\u0131laca\u011f\u0131; molek\u00fcler sonu\u00e7lara, \u00f6nceki tedavilere ve ki\u015finin durumuna g\u00f6re belirleniyor. [3]\n<p>\u0130mm\u00fcnoterapide anti-PD-1 ve anti-PD-L1 antikorlar\u0131, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin kanseri tan\u0131y\u0131p ona kar\u015f\u0131 \u00e7al\u0131\u015fmas\u0131n\u0131 engelleyen baz\u0131 sinyalleri kald\u0131r\u0131r. Yeni yakla\u015f\u0131mlardan ivonescimab ise PD-1 ile t\u00fcm\u00f6r\u00fcn damar olu\u015fumunda rol alan VEGF\u2019yi ayn\u0131 molek\u00fclde hedefleyen \u00e7ift \u00f6zg\u00fcll\u00fc bir antikordur. Ara\u015ft\u0131rmalar\u0131 s\u00fcrmektedir; Kas\u0131m 2026\u2019da, \u00f6nceden hedefe y\u00f6nelik tedavi alm\u0131\u015f belirli bir akci\u011fer kanseri grubu i\u00e7in yap\u0131lan ABD ruhsat ba\u015fvurusu mevcut haliyle onaylanmam\u0131\u015ft\u0131r. [5,6]\n<p>Ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin ba\u015fka g\u00fc\u00e7lerinden yararlanmak da m\u00fcmk\u00fcn oluyor. \u0130nterl\u00f6kin-15 (IL-15), T h\u00fccrelerini ve do\u011fal \u00f6ld\u00fcr\u00fcc\u00fc (NK) h\u00fccreleri destekleyen bir sinyal proteinidir. IL-15 yolunu uyaran bir ila\u00e7, BCG\u2019ye yan\u0131t vermeyen belirli y\u00fczeyel mesane kanserlerinde BCG ile birlikte ABD\u2019de onayl\u0131d\u0131r. NK ve genetik olarak d\u00fczenlenmi\u015f CAR-NK h\u00fccre tedavileri ise klinik ara\u015ft\u0131rmalarda de\u011ferlendiriliyor. B\u00fct\u00fcn bu geli\u015fmelerin hasta i\u00e7in de\u011feri, beklenen yarar\u0131 ve riskleri birlikte konu\u015farak kendisine uygun se\u00e7ene\u011fi bulabilmektir. [7,8]\n<p><strong>Kaynaklar \u00a0<\/strong><a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/tumor-board-review\">[1] NCI \u00b7 Tumour boards<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/biomarker-testing-cancer-treatment\">[2] NCI \u00b7 Molecular testing<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies\">[3] NCI \u00b7 Targeted therapy<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/cancer-approvals\/fda-approves-datopotamab-deruxtecan-dlnk-unresectable-or-metastatic-triple-negative-breast-cancer\">[4] FDA \u00b7 ADC \u00b7 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/immunotherapy\/checkpoint-inhibitors\">[5] NCI \u00b7 Immunotherapy<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/s206.q4cdn.com\/652410165\/files\/doc_news\/Summit-Therapeutics-Provides-Update-Regarding-Ivonescimab-Biologics-License-Application-2026.pdf\">[6] Summit \u00b7 Ivonescimab \u00b7 15 Nov 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/cancer-approvals\/fda-approves-nogapendekin-alfa-inbakicept-pmln-bcg-unresponsive-non-muscle-invasive-bladder-cancer\">[7] FDA \u00b7 IL-15<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.mdanderson.org\/research\/departments-labs-institutes\/institutes\/institute-for-cell-therapy-discovery-and-innovation\/clinical-trials.html\">[8] MD Anderson \u00b7 NK trials<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kanser tan\u0131s\u0131 alan bir ki\u015finin ilk sorular\u0131ndan biri, \u201cBenim i\u00e7in en uygun tedavi hangisi?\u201d olur. Yan\u0131t\u0131 bulmak, farkl\u0131 uzmanlar\u0131n birlikte \u00e7al\u0131\u015ft\u0131\u011f\u0131 multidisipliner yakla\u015f\u0131mla ba\u015flar. T\u0131bbi onkoloji, cerrahi, radyasyon onkolojisi, patoloji ve radyoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131; tan\u0131n\u0131n netle\u015ftirilmesine, hastal\u0131\u011f\u0131n yayg\u0131nl\u0131\u011f\u0131n\u0131n belirlenmesine ve tedavilerin do\u011fru s\u0131rayla planlanmas\u0131na yard\u0131mc\u0131 olur. Hastan\u0131n genel sa\u011fl\u0131\u011f\u0131, g\u00fcnl\u00fck ya\u015fam\u0131 ve tercihleri de<\/p>","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3763","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kanser Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tansan.com.tr\/en\/kanser-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kanser Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"og:description\" content=\"Kanser tan\u0131s\u0131 alan bir ki\u015finin ilk sorular\u0131ndan biri, \u201cBenim i\u00e7in en uygun tedavi hangisi?\u201d olur. Yan\u0131t\u0131 bulmak, farkl\u0131 uzmanlar\u0131n birlikte \u00e7al\u0131\u015ft\u0131\u011f\u0131 multidisipliner yakla\u015f\u0131mla ba\u015flar. T\u0131bbi onkoloji, cerrahi, radyasyon onkolojisi, patoloji ve radyoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131; tan\u0131n\u0131n netle\u015ftirilmesine, hastal\u0131\u011f\u0131n yayg\u0131nl\u0131\u011f\u0131n\u0131n belirlenmesine ve tedavilerin do\u011fru s\u0131rayla planlanmas\u0131na yard\u0131mc\u0131 olur. Hastan\u0131n genel sa\u011fl\u0131\u011f\u0131, g\u00fcnl\u00fck ya\u015fam\u0131 ve tercihleri de\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tansan.com.tr\/en\/kanser-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-17T20:31:45+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/\",\"url\":\"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/\",\"name\":\"Kanser Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\",\"isPartOf\":{\"@id\":\"https:\/\/tansan.com.tr\/#website\"},\"datePublished\":\"2026-11-17T18:35:49+00:00\",\"dateModified\":\"2026-11-17T20:31:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Ana sayfa\",\"item\":\"https:\/\/tansan.com.tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kanser Tedavisinde Yeni Geli\u015fmeler\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tansan.com.tr\/#website\",\"url\":\"https:\/\/tansan.com.tr\/\",\"name\":\"Tansan Onkoloji - \u00d6zel Tansan Poliklini\u011fi\",\"description\":\"Kanser Te\u015fhis ve Tedavisi\",\"publisher\":{\"@id\":\"https:\/\/tansan.com.tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tansan.com.tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/tansan.com.tr\/#organization\",\"name\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\",\"url\":\"https:\/\/tansan.com.tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"contentUrl\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"width\":274,\"height\":66,\"caption\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\"},\"image\":{\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Developments in Cancer Treatment - Tansan Private Polyclinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tansan.com.tr\/en\/kanser-tedavisinde-yeni-gelismeler\/","og_locale":"en_GB","og_type":"article","og_title":"Kanser Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","og_description":"Kanser tan\u0131s\u0131 alan bir ki\u015finin ilk sorular\u0131ndan biri, \u201cBenim i\u00e7in en uygun tedavi hangisi?\u201d olur. Yan\u0131t\u0131 bulmak, farkl\u0131 uzmanlar\u0131n birlikte \u00e7al\u0131\u015ft\u0131\u011f\u0131 multidisipliner yakla\u015f\u0131mla ba\u015flar. T\u0131bbi onkoloji, cerrahi, radyasyon onkolojisi, patoloji ve radyoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131; tan\u0131n\u0131n netle\u015ftirilmesine, hastal\u0131\u011f\u0131n yayg\u0131nl\u0131\u011f\u0131n\u0131n belirlenmesine ve tedavilerin do\u011fru s\u0131rayla planlanmas\u0131na yard\u0131mc\u0131 olur. Hastan\u0131n genel sa\u011fl\u0131\u011f\u0131, g\u00fcnl\u00fck ya\u015fam\u0131 ve tercihleri de","og_url":"https:\/\/tansan.com.tr\/en\/kanser-tedavisinde-yeni-gelismeler\/","og_site_name":"\u00d6zel Tansan Poliklini\u011fi","article_modified_time":"2026-11-17T20:31:45+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/","url":"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/","name":"New Developments in Cancer Treatment - Tansan Private Polyclinic","isPartOf":{"@id":"https:\/\/tansan.com.tr\/#website"},"datePublished":"2026-11-17T18:35:49+00:00","dateModified":"2026-11-17T20:31:45+00:00","breadcrumb":{"@id":"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/tansan.com.tr\/kanser-tedavisinde-yeni-gelismeler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana sayfa","item":"https:\/\/tansan.com.tr\/"},{"@type":"ListItem","position":2,"name":"Kanser Tedavisinde Yeni Geli\u015fmeler"}]},{"@type":"WebSite","@id":"https:\/\/tansan.com.tr\/#website","url":"https:\/\/tansan.com.tr\/","name":"Tansan Oncology - Tansan Private Polyclinic","description":"Cancer Diagnosis and Treatment","publisher":{"@id":"https:\/\/tansan.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tansan.com.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/tansan.com.tr\/#organization","name":"Tansan Private Oncology Polyclinic","url":"https:\/\/tansan.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","contentUrl":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","width":274,"height":66,"caption":"\u00d6zel Tansan Onkoloji Poliklini\u011fi"},"image":{"@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/comments?post=3763"}],"version-history":[{"count":2,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3763\/revisions"}],"predecessor-version":[{"id":3798,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3763\/revisions\/3798"}],"wp:attachment":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/media?parent=3763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}